
CAS Number2152-44-5
Synonyms(11β,16β)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione-17-valerate; β-Methasone-17-valerate; (11b,16b)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-Valerate; Betamethasone valerate; VALISONE; Betamethasone 17-valerate; (11β,16β)-9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate; 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-valerate; UNII-9IFA5XM7R2; MFCD00867446; Hormezon; Ecoval 70; Betnovate; Pentanoic acid, (11β,16β)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl ester; β-Methasone 17-valerate; Celestoderm; EINECS 218-439-3
Molecular FormulaC27H37FO6
Molecular Weight476.578
Purity98%
Density1.2±0.1 g/cm3
Boiling Point598.9±50.0 °C at 760 mmHg
Melting Point183-184ºC
Appearancewhite powder
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2152-44-5 |
| Catalog No. | 2A-9009383 |
| Chinese Name | 倍他米松戊酸酯 |
| Synonyms | (11β,16β)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate; 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione-17-valerate; β-Methasone-17-valerate; (11b,16b)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-Valerate; Betamethasone valerate; VALISONE; Betamethasone 17-valerate; (11β,16β)-9-Fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate; 9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-valerate; UNII-9IFA5XM7R2; MFCD00867446; Hormezon; Ecoval 70; Betnovate; Pentanoic acid, (11β,16β)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl ester; β-Methasone 17-valerate; Celestoderm; EINECS 218-439-3 |
| Molecular Formula | C27H37FO6 |
| Molecular Weight | 476.578 |
| Purity | 98 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 598.9±50.0 °C at 760 mmHg |
| Melting Point | 183-184ºC |
| Appearance | white powder |
| Storage Condition | Store at 2-8°C |
| Application | Betamethasone valerate (Betamethasone 17-valerate) is the 17-valerate ester of Betamethasone, a topical corticosteroid with anti-inflammatory activity. Betamethasone valerate may be used to treat recu |
| HTC | 2932999099 |
| SMILES | CCCCC(=O)OC1(C(=O)CO)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C |
| InChI | InChI=1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19-,20-,21-,24-,25-,26-,27-/m0/s1 |
| InChI Key | SNHRLVCMMWUAJD-SUYDQAKGSA-N |
| Hazard Symbols | 4.3 |
| Bioactivity | Betamethasone valerate (Betamethasone 17-valerate), the 17-valerate ester of Betamethasone, is a topical corticosteroid with anti-inflammatory activity. Betamethasone valerate is used in the treatment of recurrent aphthous stomatitis. Betamethasone valerate inhibits the binding of the radiolabeled glucocorticoid dexamethasone (3H dexamethasone) to human epidermis and mouse skin with IC50s of 5 and 6 nM, respectively[1][2][3]. Related Catalog Research Areas >> Inflammation/Immunology Signaling Pathways >> GPCR/G Protein >> Glucocorticoid Receptor In Vivo Betamethasone valerate (10 mg; 5 minutes; applied to the irritated site with a micro spatula) ointment inhibits about 50% of the ear edema without thymus atrophy[4]. Betamethasone-17-valerate ointment (50 mg) inhibits homologous passive cutaneous anaphylaxis[4]. Animal Model: Female Sprague-Dawley rats weighing 60-70 g (croton oil edema experiment)[4] Dosage: 10 mg Administration: Applied to the irritated site with a micro spatula; 5 minutes Result: Inhibited about 50% of the ear edema without thymus atrophy. References [1]. Sizílio RH, et al. Chitosan/pvp-based mucoadhesive membranes as a promising delivery system of betamethasone-17-valerate for aphthous stomatitis. Carbohydr Polym. 2018 Jun 15;190:339-345. [2]. Epstein EH Jr, et al. Glucocorticoid receptors of normal human epidermis. J Invest Dermatol. 1982 Feb;78(2):144-6. [3]. WILLIAMS DI, et al. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID. Lancet. 1964 May 30;1(7344):1177-9. [4]. Iizuka Y, et al. Two simple methods for the evaluation of topically active anti-inflammatory steroidal ointments. Agents Actions. 1981 May;11(3):254-9. Chemical & Physical Properties Density 1.2±0.1 g/cm3 Boiling Point 598.9±50.0 °C at 760 mmHg Melting Point 183-184ºC Molecular Formula C27H37FO6 Molecular Weight 476.578 Flash Point 316.0±30.1 °C Exact Mass 476.257416 PSA 100.90000 LogP 3.78 Vapour Pressure 0.0±3.8 mmHg at 25°C Index of Refraction 1.560 InChIKey SNHRLVCMMWUAJD-SUYDQAKGSA-N SMILES CCCCC(=O)OC1(C(=O)CO)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC21C Storage condition 2-8°C |
| Use of | Betamethasone valerate (Betamethasone 17-valerate), the 17-valerate ester of Betamethasone, is a topical corticosteroid with anti-inflammatory activity. Betamethasone valerate is used in the treatment of recurrent aphthous stomatitis. Betamethasone valerate inhibits the binding of the radiolabeled glucocorticoid dexamethasone (3H dexamethasone) to human epidermis and mouse skin with IC50s of 5 and 6 nM, respectively[1][2][3]. Properties Articles27 Name betamethasone valerate Synonym More Synonyms Betamethasone 17-valerate Biological Activity Description Betamethasone valerate (Betamethasone 17-valerate), the 17-valerate ester of Betamethasone, is a topical corticosteroid with anti-inflammatory activity. Betamethasone valerate is used in the treatment of recurrent aphthous stomatitis. Betamethasone valerate inhibits the binding of the radiolabeled glucocorticoid dexamethasone (3H dexamethasone) to human epidermis and mouse skin with IC50s of 5 and 6 nM, respectively[1][2][3]. Related Catalog Research Areas >> Inflammation/Immunology Signaling Pathways >> GPCR/G Protein >> Glucocorticoid Receptor References [1]. Sizílio RH, et al. Chitosan/pvp-based mucoadhesive membranes as a promising delivery system of betamethasone-17-valerate for aphthous stomatitis. Carbohydr Polym. 2018 Jun 15;190:339-345. [2]. Epstein EH Jr, et al. Glucocorticoid receptors of normal human epidermis. J Invest Dermatol. 1982 Feb;78(2):144-6. [3]. WILLIAMS DI, et al. BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROID. Lancet. 1964 May 30;1(7344):1177-9. [4]. Iizuka Y, et al. Two simple methods for the evaluation of topically active anti-inflammatory steroidal ointments. Agents Actions. 1981 May;11(3):254-9. Chemical & Physical Properties Molecular Formula C27H37FO6 Exact Mass 476.257416 PSA 100.90000 Index of Refraction 1.560 InChIKey SNHRLVCMMWUAJD-SUYDQAKGSA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Benazepril | 86541-75-5 | 2A-9009323 |
| Benazeprilat | 86541-78-8 | 2A-9009325 |
| beta-Lumicolchicine | 2A-300463 | 2A-9009380 |
| Betamethasone butyrate propionate | 5534-02-1 | 2A-9009381 |
| Betamethasone Dipropionate | 5593-20-4 | 2A-9009382 |
| Bicalutamide | 90357-06-5 | 2A-9009396 |
| Bisoprolol fumarate | 104344-23-2 | 2A-9009416 |
| Bortezomib | 179324-69-7 | 2A-9009431 |
| Buprenorphine | 52485-79-7 | 2A-9009493 |
| Calcitonin,porcine | 12321-44-7 | 2A-9009539 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA